• Benzo[a]pyrene Drives Immunosuppression in Prostate Cancer P

  2026-05-15

  This study provides direct evidence that benzo[a]pyrene (BaP), a major environmental carcinogen, promotes prostate cancer progression by enhancing tumor proliferation and suppressing anti-tumor immunity. These findings highlight crucial molecular and immunological mechanisms linking pollutant exposure to cancer aggressiveness, underscoring the need for refined experimental models and sensitive assays to advance mechanistic research.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-05-14

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) offers defined, visible molecular weight standards for accurate protein sizing in SDS-PAGE and Western blot workflows, especially where phosphoprotein analysis or fluorescent imaging is required. It is not intended for direct protein quantification or as a loading control.

• SU6656 Src Tyrosine Kinases Inhibitor: Protocols & Innovatio

  2026-05-14

  SU6656, a potent Src tyrosine kinases inhibitor, empowers both platelet biomanufacturing and radiotherapy workflows with robust, reproducible results. This guide unpacks advanced experimental protocols, practical troubleshooting, and cross-domain applications grounded in the latest peer-reviewed evidence.

• Mifepristone (RU486): Applied Workflows in Cancer & Reproduc

  2026-05-13

  Mifepristone (RU486) is redefining experimental strategies for hormone-driven cancer and reproductive biology research. Discover stepwise protocols, advanced assay adaptations, and troubleshooting approaches that unlock the full power of this high-purity APExBIO reagent.

• Cy5 Hydrazide: Advanced Carbonyl-Labeling for Protein Analys

  2026-05-13

  Cy5 hydrazide (non-sulfonated) delivers precise, high-sensitivity carbonyl group labeling for oxidative stress and nanoparticle workflows. Its compatibility with food-grade nanotechnology and robust performance in fluorescence assays make it a strategic upgrade over traditional dyes, empowering researchers in both analytical and translational domains.

• Strategic DNA Digestion: Mechanistic Insight for Translation

  2026-05-12

  This article delivers a thought-leadership perspective on the pivotal role of DNase I (RNase-free) in translational cancer research, focusing on its mechanistic underpinnings, strategic application in RNA workflows, and direct relevance to emerging findings on tumor microenvironment-driven chemoresistance. Integrating evidence from recent colorectal cancer studies, it provides actionable guidance for maximizing data reproducibility and experimental rigor in complex molecular biology settings.

• Phillygenin Attenuates Diabetic Nephropathy via Inflammatory

  2026-05-12

  This study demonstrates that phillygenin, a bioactive lignan from Forsythia suspensa, alleviates diabetic nephropathy by inhibiting inflammation and apoptosis through the TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling pathways. The findings provide mechanistic insight and preclinical support for phillygenin as a potential therapeutic for diabetic kidney disease.

• Stiripentol: Advanced LDH Inhibitor for Epilepsy Research

  2026-05-11

  Stiripentol offers researchers a robust, noncompetitive LDH inhibitor to dissect astrocyte-neuron lactate shuttle modulation and unravel mechanisms of Dravet syndrome and immunometabolic regulation. Its superior solubility and reproducibility make it a preferred choice for metabolic, neurological, and tumor microenvironment workflows.

• Necrostatin-1: Precision RIP1 Kinase Inhibitor for Necroptos

  2026-05-11

  Necrostatin-1 enables high-fidelity modulation of necroptosis in both in vitro and in vivo models, making it indispensable for dissecting RIP1 kinase signaling. With optimized workflows and robust troubleshooting, researchers can achieve reproducible, mechanistically informed results in inflammation and acute organ injury studies.

• In Vitro Inhibitors of Monkeypox: Mubritinib’s Antiviral Rol

  2026-05-10

  The referenced study systematically identified compounds with inhibitory activity against monkeypox virus (MPXV) using recombinant orthopoxvirus models. Mubritinib (TAK 165), previously noted for its mitochondrial complex I inhibition in cancer research, was validated as an effective in vitro inhibitor of both vaccinia and MPXV, suggesting new avenues for antiviral investigation.

• Universal nPEC Method for Dual-Loaded Liposome Encapsulation

  2026-05-09

  This study introduces and validates a nanoparticle exclusion chromatography (nPEC) method for accurately determining the encapsulation efficiency of dual-loaded liposomes, regardless of the drugs’ physicochemical diversity. The approach demonstrates high separation efficiency and operational simplicity, providing a robust solution for advanced drug delivery research, particularly in combination chemotherapy.

• Bifendate (DDB): Strategic Mechanisms for Translational Hepa

  2026-05-09

  This thought-leadership article offers a detailed exploration of Bifendate (DDB)’s mechanistic underpinnings, translational research parameters, and workflow guidance for liver disease models. The discussion bridges advanced biological rationale, robust experimental evidence, and strategic insights for researchers aiming to leverage DDB as a hepatoprotection agent and regulator of lipid metabolism. Unique to this analysis is a synthesis of validated protocols, competitive landscape differentiation, and a forward-looking perspective on personalized medicine, contextualized by both clinical and preclinical evidence.

• Indomethacin Sodium Trihydrate: Reliable Assay Solutions (SK

  2026-05-08

  This article addresses persistent challenges in inflammation, viability, and cytotoxicity assays, illustrating how Indomethacin Sodium Trihydrate (SKU C6491) delivers robust, reproducible results for biomedical researchers. Scenario-driven guidance covers protocol optimization, data interpretation, and supplier selection, with evidence-based recommendations rooted in published literature and laboratory best practices.

• FH1 Small Molecule: Optimizing iPS Cell Differentiation to H

  2026-05-07

  FH1 small molecule (B3700) revolutionizes hepatocyte maturation in iPS-derived cultures by doubling albumin output, enhancing CYP3A4 expression, and reducing AFP secretion. This article delivers actionable protocol parameters, troubleshooting, and insights into integrating optogenetic gene control for advanced liver cell applications.

• Live-Dead Cell Staining Kit: Precision in Calcein-AM PI Assa

  2026-05-07

  The Live-Dead Cell Staining Kit empowers researchers to distinguish viable from non-viable cells with dual Calcein-AM and Propidium Iodide staining. Its robust workflow streamlines viability and cytotoxicity assessments for advanced applications, outperforming traditional single-dye or trypan blue exclusion methods.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page